Get started
Author

Hansjakob Furrer

Cohort Profile: The Swiss HIV Cohort Study
2009 · The Swiss HIV Cohort Study, F. Schoeni-Affolter, et al. · International Journal of Epidemiology · 346
PDF
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART
2019 · Nadine Bachmann, Chantal von Siebenthal, et al. · Nature Communications · 184
PDF
Discontinuation of Secondary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
2001 · Bruno Ledergerber, Amanda Mocroft, et al. · New England Journal of Medicine · 165
PDF
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
2008 · Jerry Polesel, Gary M Clifford, et al. · AIDS · 146
Essentials from the 2015 European AIDS Clinical Society ( EACS ) guidelines for the treatment of adult HIV ‐positive persons
2015 · L Ryom, C Boesecke, et al. · HIV Medicine · 104
PDF
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia
2000 · Sabine Yerly, Laurent Kaiser, et al. · AIDS · 85
A Smoking Cessation Programme in HIV-Infected Individuals: A Pilot Study
2006 · the Swiss HIV Cohort Study, M Battegay, et al. · Antiviral Therapy · 75
Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis
1999 · Hansjakob Furrer, Raffaele Malinverni · The American Journal of Medicine · 71
Tracing HIV-1 strains that imprint broadly neutralizing antibody responses
2018 · Roger D. Kouyos, Peter Rusert, et al. · Nature · 53
PDF
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy The Swiss HIV Cohort Study
2001 · Andrée C. Friedl, Bruno Ledergerber, et al. · AIDS · 49
Survival in HIV infection: do sex and category of transmission matter?
1994 · Jan von Overbeck, Matthias Egger, et al. · AIDS · 49
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy
2010 · Janine Rohrbach, Nicola Robinson, et al. · Gut · 47
PDF
Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies
2024 · Sonja Fernbach, Nina K. Mair, et al. · The Journal of Experimental Medicine · 46
PDF
Prognostic factors for advanced‐stage human immunodeficiency virus‐associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi‐institutional retrospective study
2014 · Jorge J. Castillo, Mark Bower, et al. · Cancer · 41
Discontinuing or withholding primary prophylaxis against Mycobacterium avium in patients on successful antiretroviral combination therapy. The Swiss HIV Cohort Study
2000 · Hansjakob Furrer, Amalio Telenti, et al. · AIDS · 32
Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration
2024 · Erich Tusch, Lene Ryom, et al. · Clinical Infectious Diseases · 31
Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles
2021 · Susana Benet, Cristina Gálvez, et al. · Journal of Extracellular Vesicles · 21
PDF
The DAD Study Group. Combination antiretroviral therapy and the risk of myocardial infarction
2003 · Nina Friis‐Møller, Caroline Sabin, et al. · 17
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART
2020 · Chenjie Wan, Nadine Bachmann, et al. · Nature Communications · 13
PDF
No Effect of Pegylated Interferon-α on Total HIV-1 DNA Load in HIV-1/HCV Coinfected Patients
2018 · Victoria P Strouvelle, Dominique L Braun, et al. · The Journal of Infectious Diseases · 12
PDF
[Antibiotic prophylaxis for late blood-borne infections of joint prostheses].
2005 · M Rossi, W Zimmerli, et al. · PubMed · 9
[Sexual problems in schizophrenic patients treated by ambulatory care].
1988 · C Buddeberg, H Furrer, et al. · PubMed · 9
Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxis
2021 · Frédérique Hovaguimian, Huldrych F. Günthard, et al. · Nature Communications · 8
PDF
Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group
2021 · Huyen Nguyen, Benjamin Hampel, et al. · Clinical Infectious Diseases · 7
Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV
2024 · Paul Thoueille, Susana Alves Saldanha, et al. · Frontiers in Pharmacology · 6
PDF
Works count: 48
Citation count: 1,686
H-index: 18
I10-index: 21
Year
Topic
Type